Guideline for isolation precautions in hospitals

Infection Control and Hospital Epidemiology

Volumn 17, Issue 1, 1996, Pages 53-80

  Garner, Julia S ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HISTORY; HUMAN; INFECTION CONTROL; METHODOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; STANDARD; UNITED STATES;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; INFECTION CONTROL; PATIENT ISOLATION; UNITED STATES;

EID: 0029685966     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30142367     Document Type: Review

References (106)

1. Garner JS. The CDC Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1993;21:160-162.
2. National Communicable Disease Center. Isolation Techniques for Use in Hospitals. 1st ed. Washington, DC: US Government Printing Office; 1970. PHS publication no. 2054.
3. Centers for Disease Control. Isolation Techniques for Use in Hospitals. 2nd ed. Washington, DC: US Government Printing Office; 1975. HHS publication no. (CDC) 80-8314.
4. Garner JS, Simmons BP. CDC Guideline for Isolation Precautions in Hospitals. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control; 1983. HHS publication no. (CDC) 83-8314; Infect Control 1983;4:245-325, and Am J Infect Control 1984;12:103-163.
5. Garner JS, Simmons BP. CDC Guideline for Isolation Precautions in Hospitals. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control; 1983. HHS publication no. (CDC) 83-8314; Infect Control 1983;4:245-325, and Am J Infect Control 1984;12:103-163.
6. Garner JS, Simmons BP. CDC Guideline for Isolation Precautions in Hospitals. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control; 1983. HHS publication no. (CDC) 83-8314; Infect Control 1983;4:245-325, and Am J Infect Control 1984;12:103-163.
7. Lynch T. Communicable Disease Nursing. St. Louis, MO: Mosby; 1949.
8. Gage ND, Landon JF, Sider MT. Communicable Disease. Philadelphia, PA; FA Davis; 1959.
9. Haley RW, Shachtman RH. The emergence of infection surveillance and control programs in US hospitals: an assessment, 1976. Am J Epidemiol 1980;111:574-591.
10. Schaffner W. Infection control: old myths and new realities. Infect Control 1980;1:330-334.
11. Garner JS. Comments on CDC guideline for isolation precautions in hospitals, 1984. Am J Infect Control 1984;12:163-164.
12. Haley RW, Garner JS, Simmons BP. A new approach to the isolation of patients with infectious diseases: alternative systems. J Hosp Infect 1985;6:128-139.
13. Nauseef WM, Maki DG. A study of the value of simple protective isolation in patients with granulocytopenia. N Engl J Med 1981;304:448-453.
14. Pizzo PA. The value of protective isolation in preventing nosocomial infections in high risk patients. Am J Med 1981;70:631-637.
15. Jacobson JT, Johnson DS, Ross CA, Conti MT, Evans RS, Burke JP. Adapting disease-specific isolation guidelines to a hospital information system. Infect Control 1986;7:411-418.
16. Goldmann DA. The role of barrier precautions in infection control. J Hosp Infect 1991;18:515-523.
17. Goldmann DA, Platt R, Hopkins C. Control of hospital-acquired infections. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. Philadelphia, PA: WB Saunders; 1992:378-390.
18. Centers for Disease Control. Management of patients with suspected viral hemorrhagic fever. MMWR 1988;37(3S):1-16.
19. Centers for Disease Control. Risks associated with human parvovirus B19 infection. MMWR 1989;38:81-88, 93-97.
20. Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR 1990;39(RR-17):1-29.
21. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital - Florida. MMWR 1990;39:718-722.
22. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR 1991;40:585-591.
23. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of muttidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1993;42(RR-7):1-8.
24. Centers for Disease Control and Prevention. Draft guidelines for preventing the transmission of tuberculosis in health-care facilities, second edition. Federal Register 1993;58(195):52810-52850.
25. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of tuberculosis in health-care facilities, 1994. MMWR 1994;43(RR-13):1-132, and Federal Register 1994;59(208):54242-54303.
26. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of tuberculosis in health-care facilities, 1994. MMWR 1994;43(RR-13):1-132, and Federal Register 1994;59(208):54242-54303.
27. Centers for Disease Control. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR 1985;34:681-686, 691-695.
28. Centers for Disease Control. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. MMWR 1986;35:221-223.
29. Centers for Disease Control. Update: human immunodeficiency virus infections in health-care workers exposed to blood of infected patients. MMW 1987;36:285-289.
30. Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36(2S):1S-18S.
31. Centers for Disease Control. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in healthcare settings. MMWR 1988;37:377-382, 387-388.
32. Lynch P, Jackson MM, Cummings MJ, Stamm WE. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 1987;107:243-246.
33. Lynch P, Cummings MJ, Roberts PL, Herriott MJ, Yates B, Stamm WE. Implementing and evaluating a system of generic infection precautions: body substance isolation. Am J Infect Control 1990;18:1-12.
34. McPherson DC, Jackson MM, Rogers JC. Evaluating the cost of the body substance isolation system. J Healthcare Material Mgmt 1988;6:20-28.
35. Patterson JE, Vecchio J, Pantelick EL, et al. Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit. Am J Med 1991;91:479-483.
36. Klein BS, Perloff WH, Maki DG. Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med 1989;320:1714-1721.
37. Leclair JM, Freeman J, Sullivan BF, Crowley CM, Goldmann DA, Prevention of nosocomial respiratory syncytial virus infections through compliance with gown and glove isolation precautions. N Engl J Med 1987;317:329-334.
38. Weinstein RA, Kabins SA. Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med 1981;70:449-454.
39. Garner JS, Hierholzer WJ. Controversies in isolation policies and practices. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. 2nd ed. Baltimore, MD: Williams & Wilkins, 1993:70-81.
40. Garner JS, Hughes JM. Options for isolation precautions. Ann Intern Med 1987;107:248-250.
41. Weinstein RA, Kabins SA. Isolation practices in hospitals. Ann Intern Med 1987;107:781-782. Letter.
42. Doebbeling BN, Pfaller MA, Houston AK, Wenzel RP. Removal of nosocomial pathogens from the contaminated glove: implications for glove reuse and handwashing. Ann Intern Med 1988;109:394-398.
43. Sussman GL, Tarlo S, Dolovich J. The spectrum of IgE-mediated response to latex. JAMA 1991;255:2844-2847.
44. Bubak ME, Reed CE, Fransway AF, et al. Allergic reactions to latex among health-care workers. Mayo Clin Proc 1992;67:1075-1079.
45. Albert RK, Condie F. Hand-washing patterns in medical intensive care units. N Engl J Med 1981;304:1465-1466.
46. Preston GA, Larson EL, Stamm WE. The effect of private isolation rooms on patient care practices, colonization, and infection in an intensive care unit. Am J Med 1981;70:641-645.
47. Larson E, Leyden JJ, McGinley KJ, Grove GL, Talbot GH. Physiologic and microbiologie changes in skin related to frequent handwashing. Infect Control 1986;7:59-63.
48. Department of Labor, Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; proposed rule and notice of hearings. Federal Register 1989;54(102):23042-23139.
49. Doebbeling BN, Wenzel RP. The direct costs of universal precautions in a teaching hospital. JAMA 1990;264:2083-2087.
50. Eickhoff TC. The cost of prevention. Infect Dis News 1991;4:6.
51. Fahey BJ, Koziol DE, Banks SM, Henderson DK. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am J Med 1991;90:145-153.
52. Klein RS. Universal precautions for preventing occupational exposures to human immunodeficiency virus type 1. Am J Med 1991;90:141-153.
53. Wong ES, Stotka JL, Chinchilli VM, Williams DS, Stuart CG, Markowitz SM. Are universal precautions effective in reducing the number of occupational exposures among health care workers? JAMA 1991;265:1123-1128.
54. Department of Labor, Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; final rule. Federal Register 1991;56(235):64175-64182.
55. American Hospital Association. OSHA's Final Bloodborne Pathogens Standard: A Special Briefing. 1992; item no. 155904.
56. Bruning LM. The bloodborne pathogens final rule. AORN J 1993;57:439-461.
57. Jackson MM, Lynch P. An attempt to make an issue less murky: a comparison of four systems for infection precautions. Infect Control Hosp Epidemiol 1991;12:448-450.
58. Pugliese G, Lynch P, Jackson MM. Universal Precautions: Policies, Procedures, and Resources. Chicago, IL: American Hospital Association; 1991:7-87.
59. Birnbaum D, Schulzer M, Mathias RG, Kelly M, Chow AW. Adoption of guidelines for universal precautions and body substance isolation in Canadian acute-care hospitals. Infect Control Hosp Epidemiol 1990;11:465-472.
60. Lynch P, Cummings MJ, Stamm WE, Jackson MM. Handwashing versus gloving. Infect Control Hosp Epidemiol 1991;12:139. Letter.
61. Birnbaum D, Schulzer M, Mathias RG, Kelly M, Chow AW. Handwashing versus gloving. Infect Control Hosp Epidemiol 1991;12:140. Letter.
62. Gurevich I. Body substance isolation. Infect Control Hosp Epidemiol 1992;13:191. Letter.
63. Jackson MM, Lynch P. Body substance isolation. Infect Control Hosp Epidemiol 1992;13:191-192. Letter.
64. Rudnick JR, Kroc K, Manangan L, Banerjee S, Pugliese G, Jarvis W. Are US hospitals prepared to control nosocomial transmission of tuberculosis? Epidemic Intelligence Service Annual Conference, 1993;60. Abstract.
65. Institute of Medicine. Emerging Infections: Microbial Threats to Health in the United States. 1st ed. Washington, DC: National Academy Press, 1992.
66. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989-1983. MMWR 1993;42:597-599.
67. Lowbury EJL, Lilly HA, Bull JP. Disinfection of hands: removal of transient organisms. Br Med J 1964;2:230-233.
68. Sprunt K, Redmon W, Leidy G. Antibacterial effectiveness of routine handwashing. Pediatrics 1973;52:264-271.
69. Steere AC, Mallison GE Handwashing practices for the prevention of nosocomial infections. Ann Intern Med 1975;83:683-690.
70. Food and Drug Administration. The tentative final monograph for over-the-counter topical antimicrobial products. Federal Register 1978;43:1210-1249.
71. Garner JS, Favero MS. Guideline for Handwashing and Hospital Environmental Control. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control; 1985.
72. Larson E. APIC guideline for use of topical antimicrobial products. Am J Infect Control 1988;16:253-266.
73. Ehrenkranz NJ. Bland soap handwash or hand antisepsis? The pressing need for clarity. Infect Control Hosp Epidemiol 1992;13:299-301.
74. Larson E. Skin cleansing. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. 2nd ed. Baltimore, MD: Williams & Wilkins, 1993:450-459.
75. Larson EL, 1992, 1993, and 1994 Association for Professionals in Infection Control and Epidemiology Guidelines Committee. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995;23:251-269.
76. Paulssen J, Eidem T, Kristiansen R. Perforations in surgeons' gloves. J Hosp Infect 1988;11:82-85.
77. DeGroot-Kosolcharoen J, Jones JM. Permeability of latex and vinyl gloves to water and blood. Am J Infect Control 1989;17:196-201.
78. Kotilainen HR, Brinker JP, Avato JL, Gantz NM. Latex and vinyl examination gloves: quality control procedures and implications for health care workers. Arch Intern Med 1989;149:2749-2753.
79. Olsen RJ, Lynch P, Coyle MB, Cummings MJ, Bokete T, Stamm WE. Examination gloves as barriers to hand contamination and clinical practice. JAMA 1993;270:350-353.
80. Health Resources and Services Administration. Guidelines for Construction and Equipment of Hospital and Medical Facilities. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, 1984. PHS publication no. (HRSA) 84-14500.
81. American Institute of Architects, Committee on Architecture for Health. General hospital. In: Guidelines for Construction and Equipment of Hospital and Medical Facilities. Washington, DC: The American Institute of Architects Press; 1993.
82. American Society of Heating, Refrigerating, and Air Conditioning Engineers. Health facilities. In: 1991 Application Handbook. Atlanta, GA: American Society of Heating, Refrigerating, and Air Conditioning Engineers, Inc; 1991.
83. Jarvis WR, Bolyard EA, Bozzi CJ, et al. Respirators, recommendations, and regulations: the controversy surrounding protection of health care workers from tuberculosis. Ann Intern Med 1995;122:142-146.
84. Department of Health and Human Services, Department of Labor. Respiratory protective devices: final rules and notice. Federal Register 1995;60(110):30336-30402.
85. Rutula WA, Mayhall CG. The Society for Hospital Epidemiology of America position paper: medical waste. Infect Control Hosp Epidemiol 1992;13:38-48.
86. Rhame FS. The inanimate environment. In: Bennett JV, Brachman PS, eds. Hospital Infections. 3rd ed. Boston, MA: Little, Brown and Co; 1992:299-333.
87. Rutula WA. Disinfection, sterilization, and waste disposal. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. 2nd ed. Baltimore, MD: Williams & Wilkins, 1993:460-495.
88. Maki DG, Alvarado C, Hassemer C. Double-bagging of items from isolation rooms is unnecessary as an infection control measure: a comparative study of surface contamination with single and double bagging. Infect Control 1986;7:535-537.
89. American Society for Healthcare Central Services. Recommended Practices for Central Service: Sterilization. Chicago, IL: American Hospital Association; 1988.
90. American Society for Healthcare Central Services. Recommended Practices for Central Service: Decontamination. Chicago, IL: American Hospital Association; 1990.
91. Rutula WA. APIC guideline for selection and use of disinfectants. Am J Infect Control 1990;18:99-117.
92. Bond WW, Ott BJ, Franke KA, McCracken JE. Effective use of liquid chemical germicides on medical devices: instrument design problems. In: Block SS, ed. Disinfection, Sterilization, and Preservation. 4th ed. Philadelphia, PA: Lea and Febiger, 1991:1097-1106.
93. Favero MS, Bond WW. Sterilization, disinfection, and antisepsis. In: Ballows A, Hausler WJ, Herrmann KL, Isenberg HO, Shadomy HJ, eds, Manual of Clinical Microbiology. 5th ed. Washington, DC: American Society for Microbiology; 1991:183-200.
94. Favero MS, Bond WW. Chemical disinfection of medical and surgical materials. In: Block SS, ed. Disinfection, Sterilization, and Preservation. 4th ed. Philadelphia, PA: Lea and Febiger, 1991:617-641.
95. Pugliese G, Hunstiger CA. Central services, linens, and laundry. In: Bennett JV, Brachman PS, eds. Hospital Infections. 3rd ed. Boston, MA: Little, Brown and Co; 1992:335-344.
96. Joint Committee on Healthcare Laundry Guidelines. Guidelines for Healthcare Linen Service - 1994. Hallandale, FL: Textile Rental Services Association of America; 1994.
97. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Am J Infect Control 1995;23:87-94, Infect Control Hosp Epidemiol 1995;16:105-113, and MMWR 1995; 44(No. RR-12):1-13.
98. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Am J Infect Control 1995;23:87-94, Infect Control Hosp Epidemiol 1995;16:105-113, and MMWR 1995; 44(No. RR-12):1-13.
99. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Am J Infect Control 1995;23:87-94, Infect Control Hosp Epidemiol 1995;16:105-113, and MMWR 1995; 44(No. RR-12):1-13.
100. Tablan OC, Anderson LJ, Arden NH, Breiman KF, Butler JC, McNeil MM, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia. Part I: issues on prevention of nosocomial pneumonia - 1994. Am J Infect Control 1994;22:247-266, Infect Control Hosp Epidemiol 1994;15:587-604, and American Association of Respiratory Care 1994;12:1191-1209.
101. Tablan OC, Anderson LJ, Arden NH, Breiman KF, Butler JC, McNeil MM, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia. Part I: issues on prevention of nosocomial pneumonia - 1994. Am J Infect Control 1994;22:247-266, Infect Control Hosp Epidemiol 1994;15:587-604, and American Association of Respiratory Care 1994;12:1191-1209.
102. Tablan OC, Anderson LJ, Arden NH, Breiman KF, Butler JC, McNeil MM, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia. Part I: issues on prevention of nosocomial pneumonia - 1994. Am J Infect Control 1994;22:247-266, Infect Control Hosp Epidemiol 1994;15:587-604, and American Association of Respiratory Care 1994;12:1191-1209.
103. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia. Part II: recommendations for prevention of nosocomial pneumonia. Am J Infect Control 1994;22:266-292, Infect Control Hosp Epidemiol 1994;15:604-627, and American Association of Respiratory Care 1994;12:1209-1236.
104. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia. Part II: recommendations for prevention of nosocomial pneumonia. Am J Infect Control 1994;22:266-292, Infect Control Hosp Epidemiol 1994;15:604-627, and American Association of Respiratory Care 1994;12:1209-1236.
105. Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia. Part II: recommendations for prevention of nosocomial pneumonia. Am J Infect Control 1994;22:266-292, Infect Control Hosp Epidemiol 1994;15:604-627, and American Association of Respiratory Care 1994;12:1209-1236.
106. Centers for Disease Control and Prevention. Update: management of patients with suspected viral hemorrhagic fever - United States. MMWR 1995;44:475-479.